APA

KRAMER S. P., GOODMAN L. E., DORFMAN H., SOLOMON R., RUTENBURG A. M., PINEDA E., NASONLLULFOHN A., GABY S. D., BAKAL D., WILLIAMSON C. E., MILLER J. I., SASS S., WITTEN B. & SELIGMAN A. M. (19961201). ENZYME ALTERABLE ALKYLATING AGENTSVI. SYNTHESIS, CHEMICAL PROPERTIES, TOXICITIES, AND CLINICAL TRIAL OF HALOACETATES AND HALOACETAMIDES CONTAINING ENZYME-SUSCEPTIBLE BONDS. : Journal of the National Cancer Institute.

Chicago

KRAMER S P, GOODMAN L E, DORFMAN H, SOLOMON R, RUTENBURG A M, PINEDA E, NASONLLULFOHN A, GABY S D, BAKAL D, WILLIAMSON C E, MILLER J I, SASS S, WITTEN B and SELIGMAN A M. 19961201. ENZYME ALTERABLE ALKYLATING AGENTSVI. SYNTHESIS, CHEMICAL PROPERTIES, TOXICITIES, AND CLINICAL TRIAL OF HALOACETATES AND HALOACETAMIDES CONTAINING ENZYME-SUSCEPTIBLE BONDS. : Journal of the National Cancer Institute.

Harvard

KRAMER S. P., GOODMAN L. E., DORFMAN H., SOLOMON R., RUTENBURG A. M., PINEDA E., NASONLLULFOHN A., GABY S. D., BAKAL D., WILLIAMSON C. E., MILLER J. I., SASS S., WITTEN B. and SELIGMAN A. M. (19961201). ENZYME ALTERABLE ALKYLATING AGENTSVI. SYNTHESIS, CHEMICAL PROPERTIES, TOXICITIES, AND CLINICAL TRIAL OF HALOACETATES AND HALOACETAMIDES CONTAINING ENZYME-SUSCEPTIBLE BONDS. : Journal of the National Cancer Institute.

MLA

KRAMER S P, GOODMAN L E, DORFMAN H, SOLOMON R, RUTENBURG A M, PINEDA E, NASONLLULFOHN A, GABY S D, BAKAL D, WILLIAMSON C E, MILLER J I, SASS S, WITTEN B and SELIGMAN A M. ENZYME ALTERABLE ALKYLATING AGENTSVI. SYNTHESIS, CHEMICAL PROPERTIES, TOXICITIES, AND CLINICAL TRIAL OF HALOACETATES AND HALOACETAMIDES CONTAINING ENZYME-SUSCEPTIBLE BONDS. : Journal of the National Cancer Institute. 19961201.